Bullous pemphigoid / pemphigoid
- (2018): Lopez AT+, Int J Dermatol Apr, Epub ahead of print [REVIEW]
Cutaneous toxicity / skin toxicity
- (2018): Sibaud V+, Ann Dermatol Venereol (French) Apr, Epub ahead of print [REVIEW]
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
Adverse reactions attributed to entire drug class 'Programmed death-ligand (PD-L1) inhibitor'
Please login to view adverse reactions.
- (2017): Rivera N+, JAMA Dermatol 153(11), 1162 (re-pigmentation)
Aspartate aminotransferase (AST) increased
- (2019): Kotwal A+, Thyroid Dec, Epub ahead of print21%
- (2017): Cukier P+, Endocr Relat Cancer 24(12), 331
- (2019): Wang BC+, Cancer Med Aug, Epub ahead of print15% (≥ grade 3) [REVIEW]
Adverse effects / adverse reactions
- (2020): Wang BC+, Oral Oncol Mar, Epub ahead of print94% (20% ≥ grade 3) [REVIEW]
- (2019): Huang YF+, Front Oncol Oct (e-Collection) [REVIEW] (with chemotherapy)
- (2017): Hu YB+, Transl Lung Cancer Res 6(Suppl 1), S8 [REVIEW]
- (2017): Le Burel S+, Eur J Cancer 82, 34
